Tigermed
SZSE · 300347
Market Cap$34.1B
Revenue$7.1B
Employees11130
Listed OnSZSE
Ticker300347
CEO / ExecDr. Xiaoping Ye D.Phil, EMBA, M.D., Ph.D.
HeadquartersHangzhou
MarketMainland China
Websitewww.tigermedgrp.com
Overview
Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People's Republic of China and internationally. The company offers clinical trial operation services, such as clinical pharmacology, registration and regulatory affairs, scientific affairs, medical translation, pharmacovigilance, real-world research, third-party auditing and training, etc. for innovative drugs, generic drugs, and medical devices, as well as supporting se
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.